Skip to main content

Rubius Therapeutics, Inc.

RUBYDelisted Mar 28, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001709401

Rubius Therapeutics, Inc. was delisted on Mar 28, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 42 institutions reported holding it in 13F filings for Q4 2022, worth $11.2M in total; no superinvestor held it.

Superinvestors holding RUBY, Q4 2022

See all superinvestors

No superinvestor reported holding RUBY in Q4 2022.